US states say claims are timely in generic drug antitrust case
MLex Summary: US states opposed granting Perrigo, Actavis, Amneal, and other pharmaceutical companies a summary judgment against antitrust claims over generic drug pricing, saying that their claims are timely. See attached...To view the full article, register now.
Already a subscriber? Click here to view full article